CVE-2025-32390: fallo de gravedad alta en espocrm
EspoCRM vulnerable to HTML Injection into phishing, which may lead to account takeover
Publicada el
Aviso por correo cuando entre en el KEV, tenga PoC pública o suba de nota.
21Vexday Risk Score
Sin señal de explotación. Ningún artefacto público de explotación conocido hasta ahora.
ssvc Trackcvss 7epss 0.4%
EspoCRM is a free, open-source customer relationship management platform. Prior to version 9.0.8, HTML Injection in Knowledge Base (KB) articles leads to complete page defacement imitating the login page. Authenticated users with the read knowledge article privilege can browse to the KB article and if they submit their credentials, they get captured in plain text. The vulnerability is allowed by overly permissive HTML editing being allowed on the KB articles. Any authenticated user with the privilege to read KB articles is impacted. In an enterprise with multiple applications, the malicious KB article could be edited to match the login pages of other applications, which would make it useful for credential harvesting against other applications as well. Version 9.0.8 contains a patch for the issue.
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:A/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:P
Productos afectados
espocrm · espocrmCVEs relacionadas — espocrm
En el mismo producto, de las más peligrosas a las menos.
CVE-2026-33534MEDIUMEspoCRM has authenticated SSRF via internal-host validation bypass using alternative IPv4 notationEPSS 2.0%CVE-2025-52575MEDIUMEspoCRM vulnerable to LDAP Injection through Improper Neutralization of Special ElementsEPSS 0.8%CVE-2024-24818MEDIUMEspoCRM weakness in "Forgot password"EPSS 0.6%CVE-2026-33656CRITICALEspoCRM vulnerable to authenticated RCE via Formula with path traversal in attachment `sourceId`, exploitable by admin userEPSS 0.5%CVE-2026-33733HIGHEspoCRM has Admin TemplateManager path traversal that allows arbitrary file read write and deleteEPSS 0.4%CVE-2025-32789LOWEspoCRM Allows Potential Disclosure of Sensitive Information in the User Sorting FunctionEPSS 0.4%